Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z003309 | — |
No symptoms or side effects were reported by HCP; HCP reporting that a patient received a dose of improperly stored PROQUAD. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered following the excursion. HCP reported; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided. On 16-JUL-2025, the patient received a dose of improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Z003309, has been verified to be valid, expiration date not reported but upon internal validation established as 21-JUL-2026) 0.5 mL (route, anatomical location were not reported) as prophylaxis. The health care professional (HCP) reported that she did not know the date the excursion occurred, but knew the Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was administered following the excursion. No symptoms or side effects were reported. The operator of device was HCP. It was reported that the temperature was 52.2 farenheit (F), it was unknown time frame.
Sterile diluent